These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 17437611)
21. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Praschak-Rieder N; Wilson AA; Hussey D; Carella A; Wei C; Ginovart N; Schwarz MJ; Zach J; Houle S; Meyer JH Biol Psychiatry; 2005 Nov; 58(10):825-30. PubMed ID: 16026765 [TBL] [Abstract][Full Text] [Related]
22. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327 [TBL] [Abstract][Full Text] [Related]
23. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Oquendo MA; Hastings RS; Huang YY; Simpson N; Ogden RT; Hu XZ; Goldman D; Arango V; Van Heertum RL; Mann JJ; Parsey RV Arch Gen Psychiatry; 2007 Feb; 64(2):201-8. PubMed ID: 17283287 [TBL] [Abstract][Full Text] [Related]
24. Cerebral serotonin transporter binding is inversely related to body mass index. Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236 [TBL] [Abstract][Full Text] [Related]
25. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363 [TBL] [Abstract][Full Text] [Related]
26. Relationship between neuroticism personality trait and serotonin transporter binding. Takano A; Arakawa R; Hayashi M; Takahashi H; Ito H; Suhara T Biol Psychiatry; 2007 Sep; 62(6):588-92. PubMed ID: 17336939 [TBL] [Abstract][Full Text] [Related]
27. Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study. Kaasinen V; Aalto S; NAgren K; Hietala J; Sonninen P; Rinne JO J Neural Transm (Vienna); 2003 Jun; 110(6):591-601. PubMed ID: 12768355 [TBL] [Abstract][Full Text] [Related]
28. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148 [TBL] [Abstract][Full Text] [Related]
29. Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain. Yamamoto S; Onoe H; Tsukada H; Watanabe Y Synapse; 2007 Sep; 61(9):724-31. PubMed ID: 17559093 [TBL] [Abstract][Full Text] [Related]
30. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease. Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418 [TBL] [Abstract][Full Text] [Related]
31. SERT-ainly involved in depression, but when? Sibille E; Lewis DA Am J Psychiatry; 2006 Jan; 163(1):8-11. PubMed ID: 16390880 [No Abstract] [Full Text] [Related]
32. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Politis M; Wu K; Loane C; Kiferle L; Molloy S; Brooks DJ; Piccini P Neurobiol Dis; 2010 Oct; 40(1):216-21. PubMed ID: 20594979 [TBL] [Abstract][Full Text] [Related]
33. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression. Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158 [TBL] [Abstract][Full Text] [Related]
34. The serotonin transporter and 5HT2A receptor in rat brain after localized lesions. Dam H; Mellerup ET; Plenge P; Winther R; Wörtwein G Neurol Res; 2007 Oct; 29(7):717-22. PubMed ID: 17711618 [TBL] [Abstract][Full Text] [Related]
35. Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias. Roussakis AA; Politis M; Towey D; Piccini P Neurology; 2016 Mar; 86(12):1152-8. PubMed ID: 26920358 [TBL] [Abstract][Full Text] [Related]
36. Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies. Pagano G; Niccolini F; Fusar-Poli P; Politis M Ann Neurol; 2017 Feb; 81(2):171-180. PubMed ID: 28019672 [TBL] [Abstract][Full Text] [Related]
37. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging. Nye JA; Purselle D; Plisson C; Voll RJ; Stehouwer JS; Votaw JR; Kilts CD; Goodman MM; Nemeroff CB Depress Anxiety; 2013 Oct; 30(10):902-7. PubMed ID: 23526784 [TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. Frankle WG; Huang Y; Hwang DR; Talbot PS; Slifstein M; Van Heertum R; Abi-Dargham A; Laruelle M J Nucl Med; 2004 Apr; 45(4):682-94. PubMed ID: 15073266 [TBL] [Abstract][Full Text] [Related]
39. A positron emission tomography study of the serotonergic system in relation to anxiety in depression. Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068 [TBL] [Abstract][Full Text] [Related]